Skip to content

A retrospective cohort study on the safety and clinical efficacy of a new anastomosis to reconstruct ileocecal valve function in laparoscopic radical resection of right colon cancer

A retrospective cohort study on the safety and clinical efficacy of a new anastomosis to reconstruct ileocecal valve function in laparoscopic radical resection of right colon cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500107429
Enrollment
Unknown
Registered
2025-08-11
Start date
2025-08-25
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon Cancer

Interventions

Conventional anastomosis group:None
Reconstruction ileocecal anastomosis group:None

Sponsors

Department of General Hospital, Second affiliated hospital, Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) The subjects were 18-80 years old; (2) ASA score <= 3; (3) patients first diagnosed with tumor located in the appendix, ileocecum, ascending colon, hepatic flexure of colon and right 1/3 of transverse colon, or patients requiring additional surgery due to endoscopic resection; (4) no history of other gastrointestinal diseases (except intestinal polyps and gallstones) (5) complete clinical data.

Exclusion criteria

Exclusion criteria: (1) patients with concurrent malignant tumors in other parts of the body; (2) patients with other infectious diseases or autoimmune diseases (such as Crohn's disease); (3) The surgical plan changed, and the resection range did not include the ileocecal valve; (4) clinical data are missing.

Design outcomes

Primary

MeasureTime frame
30-day complication;

Secondary

MeasureTime frame
the first flatus post operation;the first defecation time post operation;the first time to eat forming food post operation;stool forming time post operation;post operation hospitalizaition time;operation time;Plasma nontarget metabonomics;Faeces metagenome;Faeces 16srRNA;Faeces metabolomics;Blood sugar;Blood fat;Glycosylated hemoglobin;inflamatory biomarker;

Countries

China

Contacts

Public ContactWeiDong Xiao

The second affiliated hospital of army military medical university

weidong.xiao@126.com+86 177 8387 9798

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026